Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Access Ports”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04577950
What this trial is testing

A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Centre Hospitalier Universitaire Vaudois 120
Not applicableStudy completedNCT05209828
What this trial is testing

Post-market Clinical Follow-up of Pfmmedical Ports

Who this might be right for
Vascular Access PortPatient Satisfaction
pfm medical gmbh 149
Not applicableStudy completedNCT00386451
What this trial is testing

Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure

Who this might be right for
Neoplasms
University Hospital, Ghent 60
Post-approval studies (Phase 4)Ended earlyNCT03523091
What this trial is testing

OnabotulinumtoxinA Bladder Injection Study

Who this might be right for
Overactive BladderOveractive Bladder SyndromeUrinary Urgency+3 more
Corewell Health East 6
Early research (Phase 1)Study completedNCT04050670
What this trial is testing

Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

Who this might be right for
Healthy
Eli Lilly and Company 54
Not applicableWithdrawnNCT06259266
What this trial is testing

Catheter Dysfunction Rate in Patients Undergoing Kidney Replacement Therapy. Evaluation of the Safety and Efficacy of Anti-reflux Valves Without Heparin Lock Solution

Who this might be right for
Chronic Renal FailureHaemodialysis, Haemodiafiltration, HaemofiltrationKidney Replacement Therapy+1 more
University Hospital, Clermont-Ferrand
Post-approval studies (Phase 4)UnknownNCT04054128
What this trial is testing

Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients

Who this might be right for
End Stage Renal DiseaseVascular Access ComplicationCatheter Complications+2 more
Hospital General "Dr. Miguel Silva" de Morelia 60
Post-approval studies (Phase 4)Study completedNCT00994136
What this trial is testing

Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters

Who this might be right for
Oncology, MedicalHematologic Disease
Universitaire Ziekenhuizen KU Leuven 1,100
Testing effectiveness (Phase 2)Study completedNCT02710526
What this trial is testing

Phase II Pharmacokinetics Study of CAM2038

Who this might be right for
Opioid Use DisorderChronic Pain
Braeburn Pharmaceuticals 66
Large-scale testing (Phase 3)Study completedNCT00871416
What this trial is testing

Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 48
Early research (Phase 1)Study completedNCT03586843
What this trial is testing

JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose

Who this might be right for
Obesity
Janssen Research & Development, LLC 52
Early research (Phase 1)Study completedNCT04582448
What this trial is testing

A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 25
Large-scale testing (Phase 3)Study completedNCT00290342
What this trial is testing

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 458
Not applicableStudy completedNCT02112006
What this trial is testing

Comparing Two Injection Sites of Local Anesthetic for Hand Surgery

Who this might be right for
Hand InjuryWrist InjuryFinger Injury
Jose Soberon, MD 60
Early research (Phase 1)Study completedNCT01785329
What this trial is testing

Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 60
Large-scale testing (Phase 3)Study completedNCT00412854
What this trial is testing

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Who this might be right for
TetanusDiphtheriaAcellular Pertussis
GlaxoSmithKline 660
Not applicableLooking for participantsNCT05781295
What this trial is testing

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology

Who this might be right for
ChildrenMedical DevicePrimary Prevention+1 more
Institut Curie 148
Post-approval studies (Phase 4)Study completedNCT02860299
What this trial is testing

Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used

Who this might be right for
Acute Renal Insufficiency
Centre Hospitalier Universitaire Dijon 76
Large-scale testing (Phase 3)Study completedNCT00843687
What this trial is testing

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Early research (Phase 1)Study completedNCT03232983
What this trial is testing

LY900014 Formulation at Different Injection Sites in Healthy Participants

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 28
Next Page